EXICURE, INC. Interest Expense Nonoperating
EXICURE, INC. (XCUR) reported Interest Expense Nonoperating of $1.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-03-25
- EXICURE, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $1.00K.
- EXICURE, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. interest expense nonoperating for the quarter ending 2024-12-31 was $0.00.
- EXICURE, INC. interest expense nonoperating for the quarter ending 2024-09-30 was $12.00K.
- EXICURE, INC. interest expense nonoperating for fiscal 2025 was $1.00K, a 94.44% decline from fiscal 2024.
- EXICURE, INC. interest expense nonoperating for fiscal 2024 was $18.00K.
- EXICURE, INC. interest expense nonoperating for fiscal 2023 was $0.00.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $12.00K derived: sum of 2 quarters · filed 2026-03-25 | $18.00K derived: sum of 3 quarters · filed 2026-03-25 | $18.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $12.00K 10-Q · filed 2025-11-07 | $18.00K derived: sum of 2 quarters · filed 2025-11-07 | $18.00K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $6.00K 10-Q · filed 2024-08-13 | $6.00K 10-Q · filed 2024-08-13 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $0.00 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |